AU2003218833A8 - Listeria monocytogenes ctsr mutants presenting low virulence and stress-resistance - Google Patents

Listeria monocytogenes ctsr mutants presenting low virulence and stress-resistance

Info

Publication number
AU2003218833A8
AU2003218833A8 AU2003218833A AU2003218833A AU2003218833A8 AU 2003218833 A8 AU2003218833 A8 AU 2003218833A8 AU 2003218833 A AU2003218833 A AU 2003218833A AU 2003218833 A AU2003218833 A AU 2003218833A AU 2003218833 A8 AU2003218833 A8 AU 2003218833A8
Authority
AU
Australia
Prior art keywords
ctsr
stress
resistance
listeria monocytogenes
low virulence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003218833A
Other versions
AU2003218833A1 (en
Inventor
Michiel Kleerebezem
Kimon Andreas Karatzas
Willem Meindert De Vos
Tjakko Abee
Maria Henrica Jacoba Bennik
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wageningen Centre for Food Sciences
Original Assignee
Wageningen Centre for Food Sciences
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wageningen Centre for Food Sciences filed Critical Wageningen Centre for Food Sciences
Publication of AU2003218833A8 publication Critical patent/AU2003218833A8/en
Publication of AU2003218833A1 publication Critical patent/AU2003218833A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/32—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bacillus (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/335—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Lactobacillus (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU2003218833A 2002-03-11 2003-03-11 Listeria monocytogenes ctsr mutants presenting low virulence and stress-resistance Abandoned AU2003218833A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP02075946 2002-03-11
EP02075946.0 2002-03-11
PCT/NL2003/000178 WO2003076463A2 (en) 2002-03-11 2003-03-11 Listeria monocytogenes ctsr mutants presenting low virulence and stress-resistance

Publications (2)

Publication Number Publication Date
AU2003218833A8 true AU2003218833A8 (en) 2003-09-22
AU2003218833A1 AU2003218833A1 (en) 2003-09-22

Family

ID=27798858

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003218833A Abandoned AU2003218833A1 (en) 2002-03-11 2003-03-11 Listeria monocytogenes ctsr mutants presenting low virulence and stress-resistance

Country Status (2)

Country Link
AU (1) AU2003218833A1 (en)
WO (1) WO2003076463A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE503838T1 (en) * 2003-10-28 2011-04-15 Friesland Brands Bv SITE-SPECIFIC ADMINISTRATION OF ACTIVE SUBSTANCES IN THE INTESTINAL
WO2022263504A1 (en) * 2021-06-17 2022-12-22 Dsm Ip Assets B.V. Improved bacillus host cell

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2404988A1 (en) * 2000-04-11 2001-10-18 Institut Pasteur Listeria monocytogenes genome, polypeptides and uses

Also Published As

Publication number Publication date
AU2003218833A1 (en) 2003-09-22
WO2003076463A8 (en) 2004-10-07
WO2003076463A2 (en) 2003-09-18
WO2003076463A3 (en) 2003-12-11

Similar Documents

Publication Publication Date Title
HU0301191D0 (en) Visual and scene graph interfaces
EP1676187A4 (en) Visual and scene graph interfaces
EP1513924A4 (en) Attenuated listeria spp. and methods for using the same
HK1082242A1 (en) Rare earth metal compounds, methods of making, and methods of using the same
GB0228984D0 (en) Hardfacing alloy methods and products
AU2003262900A8 (en) Systems and methods for forming metal oxides using metal organo-amines and metal organo-oxides
HRP20050149A2 (en) Aripiprazole complex formulation and method
GB0411940D0 (en) Methods and compositions
EP1675538A4 (en) Interlaced compositions and methods of production
EP1701725A4 (en) Methods and compositions
AU2003239614A8 (en) Cardiolipin compositions, methods of preparation and use
EP1487965A4 (en) Minicell compositions and methods
AU2003300315A1 (en) Anti-wicking protective outerwear and methods of making and using same
GB0208081D0 (en) Skincare compositions and methods
EP1617872A4 (en) Methods and compositions for enhancing immune response
HK1061146A2 (en) Food and beverages
AP2005003316A0 (en) Methods and compositions for immunization against HIV
AU2003218833A8 (en) Listeria monocytogenes ctsr mutants presenting low virulence and stress-resistance
EP1491098A4 (en) Process for producing basic seasoning for multipurpose and utilization of the same
AU2003225710A8 (en) Composition and method for enhancing immune response
EP1583557A4 (en) Vaccine compositions and methods
AU2003215054A8 (en) Vacuum compression brazing furnace and method of using same
EP1608970A4 (en) Ccn3 compositions and methods
AU2003268078A8 (en) Levothyroxine compositions and methods
GB0300687D0 (en) Quenching method and furnace

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase